Literature DB >> 32274597

Adrenaline Facilitates Synaptic Transmission by Synchronizing Release of Acetylcholine Quanta from Motor Nerve Endings.

Venera Khuzakhmetova1, Ellya Bukharaeva2.   

Abstract

The long history of studies on the effect of catecholamines on synaptic transmission does not answer the main question about the mechanism of their action on quantal release in the neuromuscular junction. Currently, interest in catecholamines has increased not only because of their widespread use in the clinic for the treatment of cardiovascular and pulmonary diseases but also because of recent data on their possible use for the treatment of certain neurodegenerative diseases, muscle weakness and amyotrophic sclerosis. Nevertheless, the effects and mechanisms of catecholamines on acetylcholine release remain unclear. We investigated the action of noradrenaline and adrenaline on the spontaneous and evoked quantal secretion of acetylcholine in the neuromuscular junction of the rat soleus muscle. Noradrenaline (10 μM) did not change the spontaneous acetylcholine quantal release, the number of released quanta after nerve stimulation, or the timing of the quantal secretion. However, adrenaline at the same concentration increased spontaneous secretion by 40%, increased evoked acetylcholine quantal release by 62%, and synchronized secretion. These effects differ from those previously described by us in the synapses of the frog cutaneous pectoris muscle and mouse diaphragm. This indicates specificity in catecholamine action that depends on the functional type of muscle and the need to take the targeted type of muscle into account in clinical practice.

Entities:  

Keywords:  Catecholamine; Neuromuscular junction; Quantal acetylcholine release; Timing of the evoked quantal secretion

Year:  2020        PMID: 32274597     DOI: 10.1007/s10571-020-00840-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  22 in total

1.  Noradrenaline synchronizes evoked quantal release at frog neuromuscular junctions.

Authors:  E A Bukcharaeva; K C Kim; J Moravec; E E Nikolsky; F Vyskocil
Journal:  J Physiol       Date:  1999-06-15       Impact factor: 5.182

Review 2.  β-Adrenergic modulation of skeletal muscle contraction: key role of excitation-contraction coupling.

Authors:  Simeon P Cairns; Fabio Borrani
Journal:  J Physiol       Date:  2015-11-01       Impact factor: 5.182

3.  Modulation of the kinetics of evoked quantal release at mouse neuromuscular junctions by calcium and strontium.

Authors:  Ellya A Bukharaeva; Dmitry Samigullin; Eugeny E Nikolsky; Lev G Magazanik
Journal:  J Neurochem       Date:  2006-12-22       Impact factor: 5.372

4.  Adrenotropic receptors in skeletal muscle.

Authors:  W C Bowman; C Raper
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

5.  Impact of salbutamol on muscle metabolism assessed by ³¹P NMR spectroscopy.

Authors:  N Decorte; L Lamalle; P G Carlier; E Giacomini; M Guinot; P Levy; S Verges; B Wuyam
Journal:  Scand J Med Sci Sports       Date:  2014-09-17       Impact factor: 4.221

Review 6.  Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment.

Authors:  Andrew G Engel; Xin-Ming Shen; Duygu Selcen; Steven M Sine
Journal:  Lancet Neurol       Date:  2015-04       Impact factor: 44.182

7.  The effects of beta-adrenoceptor activation on contraction in isolated fast- and slow-twitch skeletal muscle fibres of the rat.

Authors:  S P Cairns; A F Dulhunty
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations.

Authors:  Georgina Burke; Andrew Hiscock; Andrea Klein; Erik H Niks; Marion Main; Adnan Y Manzur; Joanne Ng; Catherine de Vile; Francesco Muntoni; David Beeson; Stephanie Robb
Journal:  Neuromuscul Disord       Date:  2012-12-05       Impact factor: 4.296

Review 9.  β2-Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS).

Authors:  Raymond T Bartus; Alexandre Bétourné; Anthony Basile; Bethany L Peterson; Jonathan Glass; Nicholas M Boulis
Journal:  Neurobiol Dis       Date:  2015-10-14       Impact factor: 5.996

10.  Effects of the ß2-adrenoceptor agonist, albuterol, in a mouse model of anti-MuSK myasthenia gravis.

Authors:  Nazanin Ghazanfari; Marco Morsch; Nigel Tse; Stephen W Reddel; William D Phillips
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

View more
  2 in total

Review 1.  The emerging role of the sympathetic nervous system in skeletal muscle motor innervation and sarcopenia.

Authors:  Osvaldo Delbono; Anna Carolina Zaia Rodrigues; Henry Jacob Bonilla; Maria Laura Messi
Journal:  Ageing Res Rev       Date:  2021-02-18       Impact factor: 10.895

Review 2.  Adrenoceptors Modulate Cholinergic Synaptic Transmission at the Neuromuscular Junction.

Authors:  Ellya Bukharaeva; Venera Khuzakhmetova; Svetlana Dmitrieva; Andrei Tsentsevitsky
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.